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Adiposity or gaining weight increases risk of breast cancer in
older, postmenopausal women but may reduce risk in
premenopausal or young women (Ballard-Barbash, 1994). A
recent meta-analysis of 23 studies of current body mass index
(BMI) and risk of premenopausal breast cancer concluded that,
although there was substantial heterogeneity in the results of these
studies, BMI was inversely related to risk (Ursin et al, 1995).
Research on breast cancer in young women is inconsistent in
demonstrating whether risk is reduced with greater adiposity in
early adulthood (ages 18—25) (London et al, 1989; Lund et al,
1990) or with subsequent weight gain (Taioli et al, 1995; Mannisto
et al, 1996). There has been little research on effects of adolescent
body size (Brinton and Swanson, 1992; Ursin et al, 1994).
In a case control study of breast cancer in women under the age
of 45, we found that thin women had a greater risk of breast cancer
than did heavy women (Swanson et al, 1996). The inverse relation
was confined to early-stage breast cancer, but it did not vary by
method of breast cancer detection, indicating that it was not
explained by earlier detection among thinner women. The purpose
of this current study was to examine risk of breast cancer in these
young women in relation to adiposity in early adulthood and to
subsequent weight gain. In addition, we examined risk in relation
to perceived relative height and weight during adolescence and to
changes in these perceived relative heights and weights.
MATERIALS AND METHODS
This case control study was conducted in three geographically
defined locations in the USA, the metropolitan areas of Atlanta,
Georgia and Seattle, Washington, and five counties in central New
Jersey (Brinton et al, 1995). The protocol was approved by human
subjects review boards at each collaborating institution. All
women aged 20—44 years newly diagnosed with a first primary in
situ or invasive breast cancer in these areas during 1 May 1990 to
31 December 1992, were rapidly identified through frequent
review of hospital records. Of 1940 eligible cases identified, we
obtained interviews from 1668 (86.0%). Reasons for non-
interview included subject refusal (6.7%), physician refusal
(5.8%), death or illness (0.8%) or other reasons (0.7%). Eighty per
cent of the cases were interviewed within 6 months of diagnosis.
Control subjects were ascertained through 13 waves of random
digit telephone dialing. Sampling probabilities were varied
depending upon the age distribution of women in the areas and the
projected distributions of cases. A short telephone screener to
identify potentially eligible controls was completed at 90.5% of
16 254 telephone numbers assessed as residential, and a random
sample stratified by 5-year age groups was obtained. Of 1989
controls selected, 82 were subsequently found ineligible, and
interviews were completed on 1500 (78.7%). The overall response
rate (screening times interview) was 71.2%.
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Correspondence to: RJ CoatesStructured in-person interviews collected detailed information
on breast cancer risk factors. To aid recall, a calendar method was
used to record major life events. Cases were also asked how the
breast problems leading to diagnosis were discovered and what
treatments they had received. Information on risk factors was trun-
cated at a common reference date, the patients￿ diagnosis dates and
controls￿ screening dates.
Information on body size and weight gain was collected by
anthropometric measurement and by interview. Standing height
was measured using a stadiometer and weight by a portable digital
scale (Seca Corp., Columbia, MD, USA). Participants were asked
about their perceived relative heights and weights at interview and
at ages 9—10, 12—13 and 15—16 years: ￿Compared with other
[girls/women] your age, would you say you were a) much shorter,
b) somewhat shorter, c) about the same, d) somewhat taller, or e)
much taller?￿ and ￿Compared with other [girls/women] your age
would you say you were a) much thinner, b) somewhat thinner, c)
about the same, d) somewhat heavier, or e) much heavier?￿ The
interview asked about weight in pounds at age 20, and at the
heaviest and lightest weights subsequent to age 20. Women were
asked where they tended to gain weight and how many times they
had lost and then regained 15 or more pounds. The interview also
asked how much weight was gained during each pregnancy. This
study￿s findings of no relation between weight gain during preg-
nancy and breast cancer risk have been published (Troisi et al,
1998).
We created a number of body size and weight gain variables. BMI
(weight (kg)/height (m)2) was classified into approximate quintiles,
and decile categorizations were created for a more detailed exami-
nation of dose—response relations. Total adult weight change vari-
ables were created by subtracting the weight at age 20 from highest,
lowest and interview weights, and categories were created to
provide a range of levels while retaining sufficient numbers for rela-
tively stable risk estimates. To standardize the adult weight change
for height, we calculated change in BMI. Because younger women
may have gained weight at a rate similar to older women but had
fewer years to gain, and because rate of weight change may have a
different effect than total change, average yearly weight and BMI
change variables were computed. For changes in perceived relative
height and weight in adolescence, participants were categorized as
having increased or decreased their relative height or weight in
comparison with other girls if they changed categories from an
earlier age period to a later one.
Tumour stage, oestrogen receptor status and histological grade
(Percy et al, 1990) were obtained from the Surveillance,
Epidemiology and End Results (SEER) program (Ries et al, 1997)
records in Seattle and Atlanta. Stage and oestrogen receptor status
were obtained from subjects￿ medical records in New Jersey.
Stage was defined as in situ if the neoplasm was non-infiltrating,
localized if the invasive neoplasm was confined entirely to the
breast, regional if the tumour had extended directly beyond the
breast into surrounding tissues or into regional lymph nodes, or
distant if it had spread to sites remote from the primary tumour
by direct extension or by discontinuous metastases.
For this analysis, we excluded 21 cases who were interviewed
but who did not have a telephone at the time they were diagnosed,
and 53 cases and 105 controls for whom we were unable to obtain
either a weight or, less commonly, a height measure. Seven of
these excluded cases and 46 excluded controls had not been
measured because they were pregnant or less than 7 months
postpartum.
Multivariate logistic regression (Breslow and Day, 1980; SAS,
1992) was used to estimate the relative risks of breast cancer
associated with body size and weight change variables and their
95% confidence intervals adjusted for potential confounders. All
models included study area and age (continuous). In addition, we
adjusted for race (white, black, other), level of education († high
school, vocational/technical, some college, college graduate, post-
graduate), family history of breast cancer (none, grandmother or
half-sister, mother or sister), age at menarche (age † 11, 12, 13,
‡ 14 years), previous breast biopsy (no, yes), number of term
births and age at first term birth (no births, one birth at † age 24,
two births at † age 24, three births at † age 24, one birth at > age
24, two births at > age 24, three births at > age 24, and ‡ four
births), years of oral contraceptive use († 6 months, 7—59 months,
60—119 months and ‡ 120 months), recent alcohol consumption
(none, < 1 per day, 1—2 per day, ‡ 2 drinks per day), height
(quintiles) and number of mammograms obtained during the 
5-year period prior to 1 year before reference date (0, 1, 2, 3+). In
addition, we evaluated recency of oral contraceptive use, adoles-
cent diet, smoking, menstrual status and whether or not menstrual
cycles ever became regular as potential confounders. In this study,
physical activity (Gammon et al, 1998) and adult macronutrient
and calorie intakes (Potischman et al, 1997) had no effect on risk.
Indicator variables were created for each category or level of each
exposure variable and potential confounder. Trends in relations
between categorical variables and risk were obtained by ordering
the categories and entering an ordinal variable.
We examined possible variation in effect estimates among
subgroups and used the likelihood ratio test statistic to determine
statistical significance. Of particular interest was whether effects
might vary by age at diagnosis, menopausal status, race, BMI at
age 20, or age at menarche. In addition, to determine if the risks
differed by breast cancer stage, method of cancer detection, or
chemotherapy treatment, we conducted separate analyses for each
case subgroup.
RESULTS
Risk of breast cancer was inversely associated with BMI at inter-
view (Table 1). Trends were observed whether BMI was catego-
rized into quintiles or deciles, with risk reduced by approximately
2% for each unit increase in BMI. There was no linear trend in the
relation between BMI at age 20 and risk, but risk appeared to be
reduced among women whose BMIs were either greater or less
than those of women in the middle quantiles. BMIs at the
maximum and minimum weights attained between age 20 and
reference date were unrelated to risk (data not shown).
Weight gain between age 20 and interview was inversely related
to risk, with a trend toward a greater reduction with greater gain
(Table 2). This was true whether weight gain was measured in
kilograms or BMI units and whether women were categorized by
total or average annual weight gain. Compared with women whose
weights were relatively stable, those who gained more than 1.5 kg
per year had approximately 35% less risk. Risk was reduced by
approximately 2% for each unit increase in BMI after age 20 (data
not shown). No effects were found for change in weight from age
20 to maximum or minimum weights, losing and then regaining
15 pounds or more, or location of weight gain (data not shown).
Relations between breast cancer risk and weight gain were not
changed when BMI at age 20 was added to the regression models,
but adjustment for current BMI reduced the associations (data not
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increases in BMI of 0.1, 0.2, 0.3—0.4 and ‡ 0.5 per year were
increased from 0.91, 0.75, 0.79 and 0.68, to 0.95, 0.83, 0.87 and
0.74 respectively. Similarly, adjustment for annual increase in
BMI increased the odds ratios for current BMI quintiles 2—5 from
0.76, 0.74, 0.79 and 0.69 respectively (Table 1) to 0.78, 0.79, 0.87
and 0.83 respectively.
Among women who recalled being much shorter than other girls
when they were ages 12—13, risk of breast cancer was about 30%
less (RR = 0.68) than it was among those who recalled being about
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Table 1 Risk of breast cancer in relation to adult BMI and weight among women aged 20–44
Cases Controls
Characteristic No. % No. % RRa 95% CIa
BMIb at interview
15.0–21.5 405 (25.5) 278 (20.0) 1.0
21.6–23.6 303 (19.1) 279 (20.1) 0.76 (0.60–0.96)
23.7–25.8 301 (18.9) 279 (20.1) 0.74 (0.58–0.93)
25.9–30.3 309 (19.4) 277 (19.9) 0.79 (0.62–0.99)
30.4–54.9 272 (17.1) 277 (19.9) 0.69 (0.54–0.88)
Trend RR across quintilesc 1590(100) 1390 (100) 0.93 (0.88–0.98)
Trend RR per BMI unitd 1590 (100) 1390 (100) 0.98 (0.97–1.00)
BMI at age 20
13.4–18.5 301 (19.0) 278 (20.1) 0.79 (0.63–1.00)
18.6–19.7 318 (20.0) 276 (19.9) 0.84 (0.67–1.06)
19.8–21.0 378 (23.8) 278 (20.1) 1.0
21.1–22.7 315 (19.9) 277 (20.0) 0.85 (0.68–1.07)
22.8–44.2 275 (17.3) 276 (19.9) 0.75 (0.59–0.95)
Trend RR by quintilee 1587 (100) 1385 (100) 1.00 (0.98–1.02)
Trend RR by BMI differencef 1587 (100) 1385 (100) 0.94 (0.91–0.98)
RR = relative risk; CI = confidence interval. aAdjusted for age, study site, race, family history of breast
cancer, previous breast biopsy, education, number of live births, age at first live birth, age at menarche, oral
contraceptive use, history of mammograms, alcohol consumption and height. bBody mass index: [weight
(kg)]/[height (m)]2. cRisk associated with increase from a lower to a higher quintile category. dRisk associated
with one unit increase in BMI. eRisk associated with a difference of one quintile, either higher or lower, from
the middle (reference) quintile. fRisk associated with a one unit BMI increase or decrease from the median
BMI of 20.3 in controls.
Table 2 Risk of breast cancer in relation to change in weight and in body mass indexd from age 20 to
interview, among women age 20–44
Cases Controls
No. (%) No. (%) RRa (95% CI)a
Total weight change (kg)
Lost ³ 3 84 (5.3) 73 (5.3) 0.79 (0.53–1.17)
Gained/lost ± 2 204 (12.9) 142 (10.3) 1.0b
Gained 3–5 202 (12.7) 150 (10.8) 0.93 (0.68–1.27)
Gained 6–10 315 (19.9) 287 (20.7) 0.74 (0.56–0.98)
Gained 11–20 425 (26.8) 392 (28.3) 0.76 (0.59–1.00)
Gained ³ 21 375 (22.5) 341 (24.6) 0.72 (0.54–0.95)
Trend RR by categoryc 1503 1312 0.93 (0.87–0.98)
Trend RR per kgc 1503 1312 0.99 (0.99–1.00)
Annual weight change (kg)
Lost ³ 0.3 52 (3.3) 54 (3.9) 0.64 (0.42–0.98)
Gained/lost ± 0.2 378 (23.8) 262 (18.9) 1.0b
Gained 0.3–0.5 376 (23.7) 325 (23.5) 0.80 (0.64–1.00)
Gained 0.6–0.1 402 (25.3) 372 (26.9) 0.77 (0.62–0.96)
Gained 1.1–1.5 215 (13.6) 188 (13.6) 0.82 (0.63–1.06)
Gained ³ 1.6 164 (10.3) 184 (13.3) 0.65 (0.49–0.86)
Trend RR by category 1535 1331 0.92 (0.87–0.98)
Trend RR per kg 1535 1331 0.89 (0.79–0.99)
RR = relative risk; CI = confidence interval. aAdjusted for age, study site, race, family history of breast
cancer, previous breast biopsy, education, number of live births, age at first live birth, age at menarche, oral
contraceptive use, history of mammograms, alcohol consumption and height. bReferent. cIn the first row, risk
is estimated for a change from a lower to a higher quintile category. In the second row, risk is estimated for a
unit increase in BMI or weight (kg). Women in the weight loss category are excluded from the trend
analysis.dBody mass index: [weight (kg.)]/[height (m)]2.the same height as other girls their age (Table 3). However, there
was no trend of increased risk with increased height. Women who
recalled being much heavier were also at reduced risk, almost 50%
less (RR = 0.53) for women who were much heavier at ages
15—16. Also, women who were much thinner than other girls at
ages 15—16 were at reduced risk, although the effect was half that
of being much heavier. There were no trends across the relative
weight categories.
Changes in perceived relative weight were not associated with
risk of breast cancer, and neither were changes in perceived rela-
tive height, with one exception. Among women who recalled
becoming relatively taller compared with other girls at ages 15—16
than they were at ages 12—13, the risk of breast cancer was 0.72
times (95% CI 0.54—0.97) the risk among women who recalled
being the same relative height at both ages (data not shown).
Adjustment for the breast cancer risk factors included in all
models only modestly reduced the odds ratios for the body size
measures we examined. This was true despite the fact that, for
example, early menarche was associated with heavier weight at
age 20, greater subsequent weight gain and heavier weight at inter-
view. Similarly, the number of full-term births was positively asso-
ciated with weight gain and BMI at interview, but not BMI at age
20. Although women who were either heavier or lighter at age 20,
who subsequently gained more weight, or were heavier at inter-
view were more likely to have never developed regular menstrual
cycles, adjustment for menstrual regularity had no effect on the
odds ratios.
Relations between breast cancer risk and the adolescent and
adult BMI and weight gain variables did not vary by methods of
breast cancer detection or treatment or by category of the
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Table 3 Risk of breast cancer in relation to perceived relative height and weight during adolescence, among women age 20–44
Relative height Relative weight
Perceived Cases Controls Cases Controls
body size
No. (%) No. (%) RRa (95% CI)a No. (%) No. (%) RRa (95% CI)
Age 9–10
Much shorter/thinner 103 (6.5) 121 (8.7) 0.78 (0.58–1.05) 301 (18.9) 283 (20.4) 0.91 (0.73–1.12)
Somewhat shorter/thinner 254 (16.0) 230 (16.6) 0.98 (0.79–1.21) 336 (21.2) 297 (21.4) 0.96 (0.79–1.18)
About the same 714 (44.9) 626 (45.0) 1.0 627 (39.5) 523 (37.6) 1.0
Somewhat taller/heavier 329 (20.7) 269 (19.4) 1.03 (0.84–1.25) 276 (17.4) 235 (16.9) 0.96 (0.77–1.19)
Much taller/heavier 189 (11.9) 144 (10.4) 1.10 (0.85–1.43) 49 (3.1) 52 (3.7) 0.70 (0.46–1.08)
Age 12–13
Much shorter/thinner 82 (5.2) 105 (7.6) 0.68 (0.49–0.94) 243 (15.3) 228 (16.4) 0.88 (0.70–1.10)
Somewhat shorter/thinner 270 (17.0) 262 (18.9) 0.92 (0.74–1.13) 324 (20.4) 291 (20.9) 0.91 (0.74–1.11)
About the same 749 (47.1) 649 (46.7) 1.0 688 (43.3) 565 (40.7) 1.0
Somewhat taller/heavier 341 (21.5) 245 (17.6) 1.17 (0.96–1.43) 290 (18.3) 252 (18.1) 0.90 (0.73–1.11)
Much taller/heavier 147 (9.3) 129 (9.3) 0.93 (0.71–1.22) 44 (2.8) 54 (3.9) 0.63 (0.41–0.96)
Age 15–16
Much shorter/thinner 78 (4.9) 94 (6.8) 0.73 (0.53–1.01) 189 (11.9) 204 (14.7) 0.73 (0.58–0.93)
Somewhat shorter/thinner 328 (20.6) 292 (21.0) 0.98 (0.81–1.19) 344 (21.6) 288 (20.7) 0.95 (0.78–1.16)
About the same 824 (51.8) 712 (51.2) 1.0 779 (49.0) 631 (45.4) 1.0
Somewhat taller/heavier 279 (17.5) 215 (15.5) 1.10 (0.89–1.36) 250 (15.7) 227 (16.3) 0.85 (0.68–1.05)
Much taller/heavier 81 (5.1) 77 (5.5) 0.92 (0.66–1.30) 28 (1.8) 40 (2.9) 0.53 (0.32–0.88)
RR = relative risk; CI = confidence interval. aAdjusted for age, study site, race, family history of breast cancer, previous breast biopsy, education, number of live
births, age at first live birth, age at menarche, oral contraceptive use, history of mammograms and alcohol consumption. Perceived relative height is adjusted for
perceived relative weight and vice versa.
Table 4 Risk of breast cancer in relation to annual weight change age 20 to interview, by tumour grade, among women in Atlanta and Seattle, age 20–44
Annual weight change from Casesa Cases
age 20 to interview (kg)
No. (%) RRb (95% CI)b No. (%) RRb (95% CI)b
Low-gradee High-gradee
Lost ³ 0.3 5 (2.0) 0.32 (0.11–0.88) 19 (4.3) 1.05 (0.55–2.02)
Gained/lost ± 0.2 68 (26.7) 1.0c 79 (20.0) 1.0
Gained 0.3–0.5 59 (23.1) 0.65 (0.42–1.00) 95 (21.6) 0.98 (0.68–1.42)
Gained 0.6–0.1 67 (26.3) 0.67 (0.44–1.00) 113 (25.7) 0.92 (0.64–1.31)
Gained 1.1–1.5 39 (15.3) 0.94 (0.57–1.56) 66 (15.0) 1.14 (0.74–1.74)
Gained ³ 1.6 17 (6.7) 0.42 (0.23–0.79) 68 (15.5) 1.09 (0.71–1.68)
Total 255 (100) 440 (100)
Trend RR by categoryd 250 0.89 (0.78–1.01) 421 1.04 (0.94–1.14)
Trend RR per kgd 250 0.81 (0.63–1.03) 421 1.09 (0.91–1.28)
aHistological data were not available for New Jersey cases. The distribution of weight change in the control group was lost ³0.3 (35); no change (175); and
gained 0.3–0.5 (218), 0.6–1.0 (274), 1.1–1.5 (128), and ³1.6 (120). RR=relative risk; CI=confidence interval. bAdjusted for age, study site, race, family history of
breast cancer, previous breast biopsy, education, number of live births, age at first live birth, age at menarche, oral contraceptive use, history of mammograms,
alcohol consumption and height. cReferent. dIn the first row, risk is estimated for a change from a lower to a higher category. In the second row, risk is estimated
for an increase in 1 kg weight. Women in the weight loss category are excluded from the trend analysis. eLow-grade tumours are moderately and well
differentiated; high-grade tumours are poorly differentiated or undifferentiated.adjustment variables, but risk reduction with weight gain did vary
by cancer stage (data not shown). Risk of in situ and of local stage
breast cancer, but not regional/distant stage cancer, was reduced
with increasing weight gain. As was the case for BMI at interview
(Swanson et al, 1997), the variation in effect by stage was not
dependent upon differences in method of breast cancer detection
(by which we stratified) or by mammography history (which we
included as an adjustment variable). Risks related to BMI at age 20
and to the adolescent exposures did not vary by stage.
Because weight gain was associated with early-stage cancer
independently of the method of detection and of mammography
screening history, it seemed plausible that the effect of weight gain
might vary by tumour characteristics indicative of the rate of
breast cancer progression. Lower grade cancers, those that are
well- or moderately differentiated, have lower cell proliferation
rates and slower progression than are higher grade cancers, those
that are poorly differentiated or undifferentiated (Tabar et al,
1996). Similarly, oestrogen receptor-positive tumours may
progress more slowly than oestrogen receptor-negative tumours
(Habel and Stanford, 1993).
We found that the effects of weight gain after age 20 did not
vary by oestrogen receptor status (data not shown), but they did
vary by tumour grade (Table 4). Risk of lower grade breast cancer
was reduced among women with the greatest weight gain, and
there appeared to be a trend of reduced risk with greater gain.
However, the protective effect of weight gain was not evident for
higher grade tumours. Among women with ungraded cancers, 39%
of which were in situ and 40% of which were local, there was an
inverse relation between risk and weight gain (data not shown).
To determine whether the effect of weight gain was more influ-
enced by grade or stage, we stratified cases by both and found that
the relation appeared to be more dependent on grade than on stage
(Table 5). There was no evidence of an inverse relationship
between weight gain and risk of high-grade cancer whether it was
in situ/local stage or regional/distant stage. In contrast, with in-
situ/local stage cancer, there was a trend of reduction in risk of
low-grade cancer with weight gain. For regional/distant stage, the
number of low-grade cancers was small, but both the risk estimate
for women who gained the most weight and the trend relative risks
suggested a reduction in risk of low-grade cancer with weight gain.
DISCUSSION
The results of this study of breast cancer in young women add to
the evidence that women who gain weight after age 20 are at
reduced risk and raise the possibility that women who were either
much heavier or much lighter than average at age 20 are at reduced
risk. While it is generally accepted that current BMI is inversely
related to risk of breast cancer in young women (Ballard-Barbash,
1994; Ursin et al, 1995), it is unclear whether BMI in early adult-
hood (ages 18—25), subsequent weight gain, or both, contribute to
this inverse association. None of the published studies reported
that both women who were heavier and those who were lighter
than average in early adulthood were at reduced risk. Some
reported an inverse relation between risk and early adult BMI
(Paffenbarger et al, 1980; Willett et al, 1985; London et al, 1989;
Brinton and Swanson, 1992; Ursin et al, 1994; Huang et al, 1997;
Trentham-Dietz et al, 1997), and others reported no relation (Choi
Weight gain and risk of breast cancer 171
British Journal of Cancer (1999) 81(1), 167–174 © 1999 Cancer Research Campaign
Table 5 Risk of breast cancer in relation to annual weight change age 20 to interview, by stage and by tumour grade, among women in Atlanta and Seattle, age
20–44
Annual weight change from Casesa Cases
age 20 to interview (kg)
No. (%) RRb (95% CI)b No. (%) RRb (95% CI)b
Low-gradee High-gradee
In-situ and local stage
Lost ³ 0.3 2 (1.3) 0.20 (0.04–0.89) 6 (2.9) 0.71 (0.27–1.87)
Gained/lost ± 0.2 44 (27.5) 1.0c 41 (19.6) 1.0
Gained 0.3–0.5 44 (27.5) 0.80 (0.49–1.31) 47 (22.5) 0.94 (0.59–1.52)
Gained 0.6–1.0 35 (21.9) 0.54 (0.32–0.90) 58 (27.8) 0.93 (0.59–1.48)
Gained 1.1–1.5 22 (13.8) 0.81 (0.44–1.50) 29 (13.9) 1.05 (0.59–1.86)
Gained ³ 1.6 13 (8.1) 0.54 (0.27–1.10) 28 (13.4) 0.92 (0.52–1.66)
Total 160 (100) 209 (100)
Trend RR by categoryd 158 0.87 (0.74–1.01) 203 0.99 (0.87–1.32)
Trend RR per kgd 158 0.84 (0.63–1.13) 203 1.01 (0.80–1.27)
Regional/distant stage
Lost ³ 0.3 3 (3.3) 0.57 (0.14–2.28) 12 (5.4) 1.31 (0.59–2.90)
Gained/lost ± 0.2 24 (26.1) 1.0‡ 37 (16.7) 1.0
Gained 0.3–0.5 14 (15.2) 0.42 (0.20–0.88) 46 (20.7) 1.02 (0.63–1.67)
Gained 0.6–0.1 31 (33.7) 0.90 (0.47–1.70) 52 (23.4) 0.90 (0.55–1.46)
Gained 1.1–1.5 16 (17.4) 1.10 (0.51–2.37) 37 (16.7) 1.28 (0.74–2.22)
Gained ³ 1.6 4 (4.4) 0.20 (0.06–0.66) 38 (17.1) 1.26 (0.72–2.19)
Total 92 (100) 222 (100)
Trend RR by category 89 0.90 (0.73–1.10) 210 1.08 (0.95–1.23)
Trend RR per kg 89 0.69 (0.46–1.05) 210 1.16 (0.94–1.43)
aHistological data were not available for New Jersey cases. The distribution of weight change in the control group was lost ³ 0.3 (35); no change (175); and
gained 0.3–0.5 (218), 0.6–1.0 (274), 1.1–1.5 (128), and ³1.6 (120). R = relative risk; CI = confidence interval. bAdjusted for age, study site, race, family history of
breast cancer, previous breast biopsy, education, number of live births, age at first live birth, age at menarche, oral contraceptive use, history of mammograms,
alcohol consumption and height. cReferent. dIn the first row, risk is estimated for a change from a lower to a higher category. In the second row, risk is estimated
for an increase in 1 kg weight. Women in the weight loss category are excluded from the trend analysis. eLow-grade tumours are moderately and well-
differentiated; high-grade tumours are poorly differentiated or undifferentiated.et al, 1978; Pryor et al, 1989; Lund et al, 1990; Chu et al, 1991;
Radimer et al, 1993; Ursin et al, 1994; Ziegler et al, 1996).
Similarly, while some reported that weight gain resulted in
reduced risk (Lubin et al, 1985; Le Marchand et al, 1988; London
et al, 1989; Brinton and Swanson, 1992; Taioli et al, 1995;
Franceschi et al, 1996), others did not (Paffenbarger et al, 1980;
Lund et al, 1990; Chu et al, 1991; Radimer et al, 1993; Mannisto et
al, 1996; Ziegler et al, 1996; Huang et al, 1997; Trentham-Dietz et
al, 1997).
Both methodological differences among studies and error in
assessment of early adult body weight may contribute to the incon-
sistency in this literature. Differences in study design, populations
and analysis are associated with differences in findings on rela-
tions between current body size and breast cancer risk in young
women (Pathak and Whittemore, 1992; Ursin et al, 1995). A
detailed methodologic analysis of the literature on effects of early
adult BMI and weight gain is beyond the scope of this discussion,
but it is apparent from a brief review that neither cohort nor case
control studies are consistent in their findings. For example,
effects of weight gain have varied over time within the same
cohort (London et al, 1989; Huang et al, 1997). Small study
samples and differences in how BMI and weight gain were catego-
rized and how trends were assessed may have contributed to some
of the differences in findings. Also, although research suggests
that weights at age 18 recalled by middle-aged adults correlate
well with recorded weights (Casey et al, 1991; Huang et al, 1997),
random error in recall is likely to contribute to the inconsistency.
Since current BMI is a function of early adult weight and subse-
quent gain, error in recall of the early weight may affect whether,
in addition to current BMI, either early adult BMI, subsequent
weight gain, or both, are inversely related to risk.
Our finding that weight gain and current BMI were inversely
related to risk of early- but not late-stage breast cancer is in agree-
ment with a more consistent literature. Stage data have been used
to address the hypothesis that the inverse relation between BMI
and risk of breast cancer in young women was due to detection
bias. Only one of the published reports on weight gain presented
stage-related results (Brinton and Swanson, 1992). This study
among women participating in a breast cancer screening
programme found an inverse relation for both invasive and non-
invasive cancers, but it did not stratify by stage among the invasive
cases, and a large proportion of these cancers were screen-detected
and early-stage. All six studies in young women that reported
stage-specific information on current weight or BMI found an
inverse association with risk of early-stage cancer, but little or no
relation with risk of later stage cancer (Willett et al, 1985;
Swanson et al, 1989; Tretli, 1989; Harris et al, 1992; Ursin et al,
1994; Taioli et al, 1995). The relative consistency in the literature
for this finding suggests either that the effect of adiposity may
truly be confined to early-stage cancers or that the issue has not
been adequately researched. Our results are also consistent with
the single study of premenopausal breast cancer that reported risks
separately by grade, finding no effect of BMI on risk of poorly
differentiated cancers (Willett et al, 1985). Our finding of no vari-
ation in effect by oestrogen receptor status is consistent with the
study that examined this issue (Hislop and Coldman, 1986).
Except possibly for effects of overweight during adolescence on
breast cancer risk in young women, evidence is insufficient for a
conclusion about the effects of adolescent body size. Four other
studies (Choi et al, 1978; Hislop et al, 1986; Le Marchand et al,
1988; Ursin et al, 1994) found as we did that women who were
heavier in adolescence were at lower risk, although two have not
(Brinton and Swanson, 1992; Franceschi et al, 1996), and one
(Pryor et al, 1989) reported reduced risk. Our finding that women
who recalled being much shorter were at reduced risk is consistent
with one study (Brinton and Swanson, 1992), but not another
(Le Marchand et al, 1988). One study reported increased risk with
relative weight gain in adolescence (Ursin et al, 1994), and another
reported no evidence of an effect (Brinton and Swanson, 1992).
Our finding of a possible inverse relation between breast cancer
risk and growth in height late in adolescence is consistent with the
only other study (Li et al, 1997) that has examined this issue. Error
in the recall of adolescent body size is likely to contribute to null
findings and to inconsistencies among studies.
Although subject to the important limitation of accuracy of
recall of earlier body size information and a few potential limita-
tions of case control studies, our study has several strengths for an
examination of this topic. The study was population-based,
response rates were relatively high and most cases and controls
were interviewed within a few months of their reference dates. The
sample size was larger than many others, allowing for more
detailed examination of dose—response relations. In addition, we
were able to consider in our analysis a number of factors that
might have confounded or biased the findings, including
mammography history, method of cancer detection and tumour
pathologic characteristics. If overweight women were less inter-
ested than lower weight women in participating as controls in this
study, we may have underestimated the reduction in risk with
weight gain. Among premenopausal women with breast cancer,
overweight is associated with later stage at diagnosis and poorer
survival (Holmberg et al, 1994; Huang et al, 1997) which may lead
to a lower interview response rate among heavier, later stage cases
and an overestimate of the inverse relation between weight gain
and risk, particularly with late-stage cancer. However, a small
proportion of our cases were non-respondents because of death or
illness, and we found no relation between weight gain and risk of
late-stage cancer. Cohort studies of breast cancer risk in young
women have found that risk is reduced with adult weight gain
(London et al, 1989) and that the effects of adiposity are confined
to early-stage (Willett et al, 1985; Tretli et al, 1989) and low-grade
(Willett et al, 1985) cancers.
Reasons why weight gain may result in reduced risk of breast
cancer in young women are not well understood. Adult weight
gain primarily reflects change in body fat (Forbes and Reina,
1970; Ballard-Barbash, 1994), and some researchers have
suggested that it may be a better measure of adult adiposity than 
is BMI (Ziegler, 1997). In postmenopausal women, adiposity
increases availability of reproductive hormones, insulin and other
hormones and growth factors that may increase breast cell prolif-
eration and cancer risk (Ballard-Barbash, 1994; Stoll et al, 1994).
In premenopausal women, progesterone (Westoff et al, 1996) and
oestrogen levels (Potischman et al, 1996) may be reduced in
heavier women, which could explain the reduced risk. In addition,
both very heavy and very light weight women have been found to
be more likely to have irregular cycles (Willett et al, 1985), and we
found they were less likely to have ever had regular menstrual
cycles. Just as early physical maturation is associated with
increased risk (Stoll et al, 1994), attainment of adult height late in
the teen years may result in reduced risk (Li et al, 1997). However,
for many of these potential explanations, evidence is inconsistent
or limited. There are few studies of reproductive hormones in
relation to body size, sample sizes are small, and evidence is
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ciated with early puberty (Stoll et al, 1994), which is associated
with increased risk. In our study, we did not observe a relation
between recalled adolescent body size and cycle regularity. Also,
although insulin levels may be positively associated with risk of
breast cancer in young women (Del Giudice et al, 1998), in young
women insulin levels are positively associated cross-sectionally
with adiposity and longitudinally with subsequent weight gain
(Folsom et al, 1998). Finally, in this study as well as others, statis-
tical adjustment is made for several factors, including age at
menarche and menstrual cycle regularity, thought to mediate or be
closely associated with some of these explanatory factors.
Explanations for the inverse association between weight gain
and risk of low-grade, but not high-grade, cancers are also not
clear. For example, if the relation between breast cancer risk and
adiposity is due to the relations between adiposity and reproduc-
tive hormones, it is uncertain why weight gain or adiposity might
vary depending upon grade-related tumour biology, but not upon
oestrogen receptor status.
In conclusion, our finding that adult weight gain was associated
with reduced risk of early-stage, lower grade breast cancer, but not
later stage, higher grade cancer suggests that weight gain may
affect risk of less aggressive, but not more aggressive breast cancer
in young women. This finding is consistent with most published
epidemiologic studies on BMI and risk of breast cancers of
different stages in young women. Our finding of a curvilinear rela-
tion between risk and adiposity in adolescence and at age 20, the
inconsistencies in epidemiological studies of the effects of adoles-
cent and early adult body size on risk, and the inconsistencies in
clinical studies of relations between adult body size and hormonal
characteristics suggest that these relations may be complex.
Additional research in these areas will help improve our under-
standing of why the effects of adiposity on breast cancer risk in
young women differs from the effects in older women. Future
epidemiological research on breast cancer in young women may
yield more consistent findings if data collection includes medical
record or school record data as well as recalled information on
body size, if analysis considers the possibility of complex,
possibly non-linear relations, and if additional information on the
biological characteristics of the breast cancers is incorporated into
the studies.
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